AI assistant
Sending…
Genprex, Inc. — Director's Dealing 2019
Jan 29, 2019
35333_dirs_2019-01-29_804a1d13-d41e-435c-9c07-86fc0cb61d97.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Genprex, Inc. (GNPX)
CIK: 0001595248
Period of Report: 2019-01-25
Reporting Person: Pham Julien L (President & COO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-25 | Stock Option (Right to Buy) | $1.62 | A | 432692 | Acquired | 2029-01-25 | Common Stock (432692) | Direct |
Footnotes
F1: One thirty-sixth (1/36) of the Shares subject to the Option shall vest on each monthly anniversary of January 25, 2019 so that one hundred percent (100%) of the shares subject to the Option are vested on the third anniversary of January 25, 2019.
More from Genprex, Inc.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 21
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 23
Major Shareholding Notification
2026
Feb 11